Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points
- 1 November 2008
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 29 (11), 1048-1053
- https://doi.org/10.1086/591453
Abstract
Severity of illness is an important confounder in outcome studies involving infectious diseases. However, it is unclear whether the time at which severity of illness is measured is important. We performed a retrospective study of 328 episodes of gram-negative bacteremia in adult patients to assess the impact of the time of measurement of severity of illness on the association between empirical antimicrobial therapy received and in-hospital mortality. Using a modified Acute Physiology Score (APS), severity of illness was measured at 2 time points: (1) hospital admission and (2) 24 hours before the first culture-positive blood sample was collected. Multivariate logistic regression was used to estimate the impact of adjusting for the APS on the relationship between empirical therapy received (ie, the exposure) and in-hospital mortality (ie, the outcome). The mean APS ( ± standard deviation) of patients with bacteremia increased during their hospital stay (from 19.2 ± 11.6 at admission to 24.2 ± 13.6 at the second time point; P < .01). When examining the association between empirical antimicrobial therapy received and in-hospital mortality, and controlling for the APS, there was a trend toward a decreased impact of appropriate therapy received on in-hospital mortality. The unadjusted odds ratio (OR) for the association between appropriate therapy received and in-hospital mortality was 0.83 (95% confidence interval [CI], 0.51-1.34). After controlling for the APS at admission, this association was attenuated (OR, 0.94 [95% CI, 0.57-1.55]), and when a change in the APS was also included in the multivariate logistic regression model, the association was further attenuated (OR, 0.99 [95% CI, 0.58-1.69]). The magnitude of the association between appropriate antimicrobial therapy received and in-hospital mortality among patients with gram-negative bacteremia was sensitive to the timing of adjustment for severity of illness.Keywords
This publication has 19 references indexed in Scilit:
- A Systematic Review of the Methods Used to Assess the Association between Appropriate Antibiotic Therapy and Mortality in Bacteremic PatientsClinical Infectious Diseases, 2007
- Controlling for Severity of Illness in Assessment of the Association Between Antimicrobial-Resistant Infection and Mortality: Impact of Calculation of Acute Physiology and Chronic Health Evaluation (APACHE) II Scores at Different Time PointsInfection Control & Hospital Epidemiology, 2007
- Impact of Empiric Antibiotic Therapy on Outcomes in Patients with Pseudomonas aeruginosa BacteremiaAntimicrobial Agents and Chemotherapy, 2007
- Multidrug-resistantAcinetobacterInfection Mortality Rate and Length of HospitalizationEmerging Infectious Diseases, 2007
- Bloodstream Infections Due to Extended-Spectrum β - Lactamase-Producing Escherichia coli and Klebsiella pneumoniae : Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial TherapyAntimicrobial Agents and Chemotherapy, 2004
- Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance StudyClinical Infectious Diseases, 2004
- Pseudomonas aeruginosaBacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical OutcomeClinical Infectious Diseases, 2003
- Excess Shock and Mortality in Staphylococcus aureus Related to Methicillin ResistanceClinical Infectious Diseases, 2000
- Bacteraemia due to Escherichia coli in a Danish University Hospital, 1986-1990Scandinavian Journal of Infectious Diseases, 1995
- Klebsiella bacteremia: A review of 196 episodes during a decade (1980–1989)Scandinavian Journal of Infectious Diseases, 1991